Experts discuss the process of assessing decision-making capacity in patients with cancer.
James Masciale, PhD
Advertisement
Articles by James Masciale, PhD
Advertisement
Latest Updated Articles
Decisional Capacity Determination in Patients With CancerJune 16th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
2
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
3
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
4
Targeting KRAS in Pancreatic Cancer: What Is Daraxonrasib’s Mechanism of Action?
5